MARIANNE RIOS: Open Payments
NPI 1104409291 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,017 in 85 payments from 22 companies in 2025. Trend: 2023 $1,021 · 2024 $2,228 · 2025 $2,017
Food & beverage: $2,017
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $410 |
| ABBVIE INC. | 12 | $300 |
| AstraZeneca Pharmaceuticals LP | 10 | $298 |
| Amgen Inc. | 8 | $145 |
| PFIZER INC. | 7 | $134 |
| Exact Sciences Corporation | 5 | $105 |
| Lilly USA, LLC | 4 | $91 |
| Esperion Therapeutics, Inc. | 5 | $74 |
| Astellas Pharma US Inc | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
Products named: Ozempic, QULIPTA, AIRSUPRA, Wegovy, JARDIANCE, Repatha, BREZTRI, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
